Description

Poly(lactic-co-glycolic acid) (PLGA) Microspheres (Drug Delivery Grade) are biodegradable polymer-based particles engineered for controlled encapsulation and release of therapeutic agents. PLGA is a well-established copolymer composed of lactic acid and glycolic acid, which degrades via hydrolysis into biocompatible byproducts. This enables predictable and tunable release profiles over time.

The system supports encapsulation of small molecules, peptides, and biologics, providing protection and sustained delivery in complex environments. Particle size, polymer ratio, and formulation parameters can be adjusted to control degradation kinetics and release rates. The material is optimized for reproducibility and compatibility with pharmaceutical and biomedical workflows, making it suitable for both research and translational applications.

Key features
Biodegradable PLGA polymer system
Controlled and sustained release profiles
Tunable degradation kinetics
Compatible with a wide range of therapeutics
Reproducible particle formulation

Typical specifications
Form microspheres (powder)
Polymer poly(lactic-co-glycolic acid)
Lactide:glycolide ratio customizable
Particle size customizable
Degradation weeks to months
Sterility available upon request

Applications
Controlled drug delivery systems
Injectable therapeutics
Implantable delivery platforms
Vaccine delivery systems
Targeted therapy research